T-Cell Trafficking and Anti-Adhesion Strategies in Inflammatory Bowel Disease: Current and Future Prospects
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
T-Cell Trafficking and Anti-Adhesion Strategies in Inflammatory Bowel Disease: Current and Future Prospects
Authors
Keywords
Inflammatory Bowel Disease, Ulcerative Colitis, Progressive Multifocal Leukoencephalopathy, Clinical Remission, Natalizumab
Journal
DRUGS
Volume 74, Issue 3, Pages 297-311
Publisher
Springer Nature
Online
2014-01-22
DOI
10.1007/s40265-013-0176-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development and Maintenance of Regulatory T cells
- (2013) Naganari Ohkura et al. IMMUNITY
- Long-term Clinical Experience with Vedolizumab in Patients with Inflammatory Bowel Disease
- (2013) Asit Parikh et al. INFLAMMATORY BOWEL DISEASES
- Th17 Cytokines in Inflammatory Bowel Diseases: Discerning the Good from the Bad
- (2013) Edoardo Troncone et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Latent viral infections in young patients with inflammatory diseases treated with biological agents: Prevalence of JC virus genotype 2
- (2013) Manola Comar et al. JOURNAL OF MEDICAL VIROLOGY
- Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
- (2013) Brian G. Feagan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
- (2013) William J. Sandborn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sphingosine-1-phosphate signaling in physiology and diseases
- (2012) Yoh Takuwa et al. BIOFACTORS
- Eosinophils in infection and intestinal immunity
- (2012) Simon P. Hogan et al. CURRENT OPINION IN GASTROENTEROLOGY
- A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis
- (2012) Paul J Rutgeerts et al. GUT
- CCR9+ T cells contribute to the resolution of the inflammatory response in a mouse model of intestinal amoebiasis
- (2012) A.E. Rojas-López et al. IMMUNOBIOLOGY
- Natalizumab for moderate to severe Crohnʼs disease in clinical practice: The Mayo Clinic Rochester experience
- (2012) S. V. Kane et al. INFLAMMATORY BOWEL DISEASES
- Update on PML and PML-IRIS Occurring in Multiple Sclerosis Patients Treated With Natalizumab
- (2012) B.K. Kleinschmidt-DeMasters et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- The molecular basis of leukocyte recruitment and its deficiencies
- (2012) Sarah Schmidt et al. MOLECULAR IMMUNOLOGY
- Anti-JC virus antibodies in a large German natalizumab-treated multiple sclerosis cohort
- (2012) A. K. Trampe et al. NEUROLOGY
- Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy
- (2012) Gary Bloomgren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Medical management of Crohn's disease
- (2011) Mario Cottone et al. EXPERT OPINION ON PHARMACOTHERAPY
- The mucosal addressin cell adhesion molecule antibody PF-00547,659 in ulcerative colitis: a randomised study
- (2011) S. Vermeire et al. GUT
- Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients
- (2011) Namita Kothary et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Binucleated lymphocytes in patients with multiple sclerosis treated with natalizumab
- (2011) Mathieu Leclerc et al. LEUKEMIA & LYMPHOMA
- Development of small-molecule inhibitors of sphingosine-1-phosphate signaling
- (2011) Yvette Edmonds et al. PHARMACOLOGY & THERAPEUTICS
- Targeting leukocyte migration and adhesion in Crohn’s disease and ulcerative colitis
- (2011) Saskia Thomas et al. INFLAMMOPHARMACOLOGY
- Progressive Multifocal Leukoencephalopathy and Newer Biological Agents
- (2010) Joseph R. Berger DRUG SAFETY
- Progressive Multifocal Leukoencephalopathy in Patients on Immunomodulatory Therapies
- (2009) Eugene O. Major Annual Review of Medicine
- The Binding Specificity and Selective Antagonism of Vedolizumab, an Anti- 4 7 Integrin Therapeutic Antibody in Development for Inflammatory Bowel Diseases
- (2009) D. Soler et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Inflammatory Bowel Disease
- (2009) Clara Abraham et al. NEW ENGLAND JOURNAL OF MEDICINE
- Regulatory T cells in inflammatory bowel disease
- (2008) Elisa K Boden et al. CURRENT OPINION IN GASTROENTEROLOGY
- Antisense inhibition of ICAM-1 expression as therapy provides insight into basic inflammatory pathways through early experiences in IBD
- (2008) Jessica R Philpott et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Th17 Cell Differentiation: The Long and Winding Road
- (2008) Mandy J. McGeachy et al. IMMUNITY
- Leukocyte adhesion molecules in animal models of inflammatory bowel disease
- (2008) Jesús Rivera-Nieves et al. INFLAMMATORY BOWEL DISEASES
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More